Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy.
Croote D, Wong JJW, Pecalvel C, Leveque E, Casanovas N, Kamphuis JBJ, Creeks P, Romero J, Sohail S, Bedinger D, Nadeau KC, Chinthrajah RS, Reber LL, Lowman HB. Croote D, et al. Among authors: leveque e. J Allergy Clin Immunol. 2024 Jan;153(1):182-192.e7. doi: 10.1016/j.jaci.2023.08.035. Epub 2023 Sep 23. J Allergy Clin Immunol. 2024. PMID: 37748654 Free PMC article.
Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells.
Domagala M, Laplagne C, Leveque E, Laurent C, Fournié JJ, Espinosa E, Poupot M. Domagala M, et al. Among authors: leveque e. Cancers (Basel). 2021 Jan 6;13(2):165. doi: 10.3390/cancers13020165. Cancers (Basel). 2021. PMID: 33418996 Free PMC article. Review.
IL-17+ Mast Cell/T Helper Cell Axis in the Early Stages of Acne.
Eliasse Y, Leveque E, Garidou L, Battut L, McKenzie B, Nocera T, Redoules D, Espinosa E. Eliasse Y, et al. Among authors: leveque e. Front Immunol. 2021 Sep 28;12:740540. doi: 10.3389/fimmu.2021.740540. eCollection 2021. Front Immunol. 2021. PMID: 34650562 Free PMC article.
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.
Eugène J, Jouand N, Ducoin K, Dansette D, Oger R, Deleine C, Leveque E, Meurette G, Podevin J, Matysiak T, Bennouna J, Bezieau S, Volteau C, Thomas WEA, Chetritt J, Kerdraon O, Fourquier P, Thibaudeau E, Dumont F, Mosnier JF, Toquet C, Jarry A, Gervois N, Bossard C. Eugène J, et al. Among authors: leveque e. Mod Pathol. 2020 Mar;33(3):468-482. doi: 10.1038/s41379-019-0322-9. Epub 2019 Aug 13. Mod Pathol. 2020. PMID: 31409873 Free article.